Cartesian Therapeutics Statistics

Total Valuation

RNAC has a market cap or net worth of $180.26 million. The enterprise value is $70.58 million.

Market Cap	180.26M
Enterprise Value	70.58M

Important Dates

The next estimated earnings date is Friday, May 8, 2026, before market open.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

RNAC has 26.51 million shares outstanding. The number of shares has increased by 49.63% in one year.

Current Share Class	26.51M
Shares Outstanding	26.51M
Shares Change (YoY)	+49.63%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	60.48%
Owned by Institutions (%)	21.41%
Float	6.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	65.44
Forward PS	449.40
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	25.23
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.65

Current Ratio	8.65
Quick Ratio	8.45
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-14.82%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-30.80%
Weighted Average Cost of Capital (WACC)	6.84%
Revenue Per Employee	$37,293
Profits Per Employee	-$1.74M
Employee Count	75
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-9.19M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.52% in the last 52 weeks. The beta is 0.56, so RNAC's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	-42.52%
50-Day Moving Average	6.88
200-Day Moving Average	8.49
Relative Strength Index (RSI)	52.00
Average Volume (20 Days)	167,819

Short Selling Information

The latest short interest is 2.21 million, so 8.35% of the outstanding shares have been sold short.

Short Interest	2.21M
Short Previous Month	2.17M
Short % of Shares Out	8.35%
Short % of Float	32.39%
Short Ratio (days to cover)	14.30

Income Statement

In the last 12 months, RNAC had revenue of $2.80 million and -$130.30 million in losses. Loss per share was -$5.02.

Revenue	2.80M
Gross Profit	-55.24M
Operating Income	-86.71M
Pretax Income	-139.50M
Net Income	-130.30M
EBITDA	-83.75M
EBIT	-86.71M
Loss Per Share	-$5.02

Full Income Statement

Balance Sheet

The company has $125.14 million in cash and $12.68 million in debt, giving a net cash position of $112.46 million or $4.24 per share.

Cash & Cash Equivalents	125.14M
Total Debt	12.68M
Net Cash	112.46M
Net Cash Per Share	$4.24
Equity (Book Value)	-126.24M
Book Value Per Share	-4.85
Working Capital	114.34M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$73.94 million and capital expenditures -$5.45 million, giving a free cash flow of -$79.40 million.

Operating Cash Flow	-73.94M
Capital Expenditures	-5.45M
Depreciation & Amortization	2.96M
Net Borrowing	n/a
Free Cash Flow	-79.40M
FCF Per Share	-$3.00

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-3,099.93%
Pretax Margin	-4,987.31%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RNAC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-49.63%
Shareholder Yield	-49.63%
Earnings Yield	-71.19%
FCF Yield	-43.37%

Analyst Forecast

The average price target for RNAC is $34.00, which is 400.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$34.00
Price Target Difference	400.00%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	105.02%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 5, 2024. It was a reverse split with a ratio of 1:30.

Last Split Date	Apr 5, 2024
Split Type	Reverse
Split Ratio	1:30

Scores

RNAC has an Altman Z-Score of -3.94 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.94
Piotroski F-Score	1